Chang Gung Memorial Hospital: Alzheimer Disease trials

The registry lists 24 Alzheimer Disease studies with Chang Gung Memorial Hospital as lead sponsor. 5 are open to participants now and 0 have results posted.

Early Phase 1 1Phase 1 3Phase 2 11No phase 10(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Investigating the Effectiveness of Personalized Optimal Gamma Auditory Frequency Stimulation Intervention on Cognitive Function EnhancementNot yet recruitingNCT07690865Not applicable
• Prospective Single-Arm Safety Study of Cervical LVA in AD PatientsNot yet recruitingNCT07458620Phase 1
• Efficacy of Gamma Auditory Stimulation for Cognitive Decline in Older Adults (Study 1)RecruitingNCT07087951Not applicable
• Novel Augmentation of DAOIB and Antioxidant for Early DementiaRecruitingNCT06467539Phase 2
• The Influence of Vascular Burden, Amyloid Plaque and Tau Protein in Patients With Vascular Cognitive Impairment and Dementia With TauopathyRecruitingNCT04309253Phase 2
• The Relationship Between Obstructive Sleep Apnea and Alzheimer's Disease: Evidence and EffectivenessStatus unknownNCT05433883Not applicable
• Grounding Effect on Alzheimer's DiseaseCompletedNCT05246332Not applicable
• Smart-Cloth Care System for DementiaCompletedNCT05063045Not applicable
• The Assessment of the Diagnosis and Prognosis of Patients With Alzheimer Disease or Parkinson Disease With Cognitive Impairment by Using Diffusion MRICompletedNCT04434898
• Alzheimer's Disease: Clinical Investigation and Neuroimage Studies Including 18F-PM-PBB3 and 18F-florbetapir (AV-45) PET ExaminationStatus unknownNCT04305210Phase 2
• A Noval Tau Tracer in Young Onset DementiaStatus unknownNCT04248270Phase 1/2
• Modeling the Relationships Between Functional Connectivity and Amyloid Deposition in Alzheimer's DiseaseStatus unknownNCT04174287Phase 2
• Topography Staging and Dual Phase Image Quantification of Tau PET in Cognitive Impairment SubjectsStatus unknownNCT04169126Phase 2
• Theta-burst Stimulation on Cognitive Function in the Patients With Young-onset Alzheimer's Disease DementiaCompletedNCT04042532Not applicable
• Short-term Effects of an Inpatient Geriatric Consultation Team on Geriatric Syndrome PatientsCompletedNCT03840759Not applicable
• NMDA Enhancer for the Treatment of Mild Alzheimer's DiseaseCompletedNCT03752463Phase 2
• To Evaluate the Efficacy and Safety/Tolerability Profiles of G-CSF in Subjects With Mild to Moderate Alzheimer's DiseaseCompletedNCT03656042Phase 2
• 18F-PM-PBB3 PET Study in Tauopathy Including Alzheimer's Disease, Other Dementias and Normal ControlsCompletedNCT03625128Early Phase 1
• Tai Chi 6-Form Sports Apparatus With Alzheimer's DiseaseCompletedNCT02978768Not applicable
• Biodistribution, Pharmacokinetics, and Safety of F-18 THK-5351 PET in Alzheimer's Disease Patients and Healthy Subjects.(Positron Emission Tomograph )CompletedNCT02686216Phase 1
• DAOIB for the Treatment of Cognitive Function and Behavioral and Psychological Symptoms of DementiaCompletedNCT02103673Phase 2
• Establish Taiwan Alzheimer's Disease Neuroimaging Initiative - a Three-year Pilot StudyStatus unknownNCT01624389Not applicable
• NMDA-enhancing Agent for Treatment of Mild Cognitive Impairment and Mild Alzheimer's DiseaseCompletedNCT01600469Phase 2
• Phase II Study for Amyloid Binding Imaging Study of [18F]AV-45 in Patients With Mild Cognitive Impairment, Alzheimer's Disease and Healthy VolunteersStatus unknownNCT01238458Phase 2